Post, Annemarie E. M.
Klockgether, Thomas
Landwehrmeyer, G. Bernhard
Pandolfo, Massimo
Arnesen, Astri
Reinhard, Carola
Graessner, Holm
Funding for this research was provided by:
Third Health Programme (739510)
Article History
Received: 9 October 2020
Accepted: 9 December 2020
First Online: 18 March 2021
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: Thomas Klockgether receives/has received research support from the Deutsche Forschungsgemeinschaft (DFG), the Bundesministerium für Bildung und Forschung (BMBF), the Bundesministerium für Gesundheit (BMG), the Robert Bosch Foundation, the European Union (EU), and the National Institutes of Health (NIH). He has received consulting fees from Biohaven, Roche and UBC. He has received a speaker honorarium from Novartis and Bayer. Massimo Pandolfo has received consulting fees from ApoPharma, BioMarin, Minoryx, and Voyager Therapeutics and royalties from Athena Diagnostics. He serves as Deputy Editor of Neurology: Genetics. Holm Graessner receives/has received research support from the Deutsche Forschungsgemeinschaft (DFG), the Bundesministerium für Bildung und Forschung (BMBF), the Bundesministerium für Gesundheit (BMG) and the European Union (EU). He has received consulting fees from Roche. He has received a speaker honorarium from Takeda.